UK Pediatric Hospital’s Use of Fabric Genomics™ Platform to Achieve Faster and More Accurate Genome Interpretation to Be Discussed at Symposium

MILAN–(BUSINESS WIRE)–Fabric Genomics:


Satellite Symposium, Accurate and Rapid Genome Interpretation
in Clinical Care
, highlighting how use of Fabric Genomics’
platform has enabled faster and more accurate gene-panel testing
from annotation to clinical report

WHEN: Sunday, 17 June, 15:00 – 16:30 hours (3:00 – 4:30 p.m.)
WHERE: European Human Genetics Conference (EHGC)
MiCo – Milano Congressi, Room Amber 1
Piazzale Carlo Magno, 1, Milan, Italy

Matthew Parker, PhD, former lead bioinformatician with Sheffield
Diagnostic Genetics Service (SDGS) in the UK, will discuss the
institution’s use of Fabric Genomics’ Enterprise platform to
interpret its new genomic test for congenital metabolic disorders.
He will be joined by Fabric Genomics scientists Vanisha Mistry,
PhD, Field Application Scientist, and Francisco M. De La Vega,
DSc, Senior Vice President of Genomics.

INFO: Symposium speakers also will present data from more than 2000
clinical cases and public diseases-association study replications
demonstrating how the Fabric Enterprise algorithms VAAST™ and
Phevor™ identify disease-causing genes in various scenarios, and
present an optimal solution for triaging candidate variants
combining best-in-class filtering and algorithmic ranking.

Fabric Genomics will host an exhibitor booth at EHGC, from 16-19 June
(booth #364). Staff will demonstrate the company’s end-to-end platform
for clinical interpretation and reporting, including new
laboratory-management dashboards that enable rapid turnaround time and
escalated case management. Fabric Genomics also will present two posters:

  • Yield of Clinically Relevant Candidates in Family Genomes in the UK
    100,000 Genomes Project Using the Fabric Genomics Platform; Author:
    Melanie Babcock, PhD, Fabric Genomics (#P16.77A)
  • Speeding clinical reporting of targeted sequencing of cancer
    gene-panels through seamless integration of data quality control,
    mutation genomic and clinical annotations, and drug sensitivity
    options; Author: Francisco M. De La Vega, DSc, Fabric Genomics


Fabric Genomics
Charlene Son Rigby, 510-595-0800, ext. 106